View all projects

You are looking at projects supported by Joint Canada-Israel Health Research Program.

See related publications under each projects.

Project

Chemotherapy is the main form of treatment for cancer, but it cannot cure most types of cancer.
Region(s): Canada, Israel, China
Total Funding: CA$ 670,000.00

Project

Cellular senescence is a programmed response to oncogenic (tumour-causing) stress that aims to halt the expansion of cells with malignant potential.
Region(s): Canada, Israel, Brazil
Total Funding: CA$ 669,800.00

Project

Liver cancer is highly fatal, it has very few treatment options, and it is one of the few cancers whose incidence is rising worldwide.
Region(s): Canada, Israel, Turkey
Total Funding: CA$ 670,000.00

Project

Tumour heterogeneity is a driving force for disease progression and one of the major obstacles to effective treatment.
Region(s): Canada, Israel, India
Total Funding: CA$ 670,100.00

Project

Proteins represent the final product of genes and are implicated in governing most cellular functions.
Region(s): Canada, Israel, Brazil
Total Funding: CA$ 659,000.00

Project

The gene p53 is a well-known tumour suppressor gene that prevents cancer formation.
Region(s): Canada, Israel, Argentina
Total Funding: CA$ 669,800.00

Project

The ability of cells in the body to recognize bacteria and viruses is critical to survival.
Total Funding: CA$ 656,888.00

Project

Diseases that result from an infection are most often resolved by cells that use an immune response to clear foreign agents.
Region(s): Canada, Israel
Total Funding: CA$ 669,831.00

Project

Type B lymphocytes are a specific type of white blood cell within our immune system.
Total Funding: CA$ 498,669.00

Project

Tropical diseases in humans and livestock can cause death and remain a huge economic and social burden in developing countries.
Total Funding: CA$ 670,000.00

Pages